Mosley Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Sell
499
-411
-45% -$10.8K ﹤0.01% 373
2026
Q1
$23.2K Buy
+910
New +$24.2K 0.01% 247

Other funds holding PFE

Mosley Wealth Management's PFE Position: Q2 2026 in Review

Mosley Wealth Management reduced its Pfizer (PFE) stake by 45% in Q2 2026, selling an estimated $10.8K and leaving 499 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #373.

Mosley Wealth Management first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $23.2K in Q1 2026. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Mosley Wealth Management held 499 shares of Pfizer worth $12K as of Q2 2026.
  • Mosley Wealth Management sold 411 Pfizer shares in Q2 2026, an estimated $10.8K.
  • Pfizer made up ﹤0.01% of Mosley Wealth Management's portfolio in Q2 2026, its #373 holding.
  • Mosley Wealth Management first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Mosley Wealth Management's Pfizer position peaked at $23.2K in Q1 2026.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.